SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 7.620-3.7%2:46 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Glenn Petersen who wrote (61)9/4/2009 8:56:16 AM
From: Rock_nj   of 166
 
That harsh reality is hitting home, with the media in India criticizing the government for having no vaccine orders in place, and domestic vaccine production not due to come on-stream until next spring. The Times of India says, ’H1N1 vaccine ready, India napping’. The Indian government has responded that it is in discussions with international vaccines makers to carry out clinical trials of the vaccine in India, and to announce its first orders, of undisclosed size, this week for vaccine that would be available in December (a href="http://www.deccanherald.com/content/22883/2-foreign-firms-ready-try.html">)Deccan Herald.

blogs.nature.com

Hmmm, India set to announce its first orders, of undisclosed size, this week for vaccine that would be available in December? I wonder who could be supplying those orders? Novavax's Indian partner Cadila Pharmaceutical is publicly talking about H1N1 Swine Flu manufacturing coming online in November 2009.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext